Rare 'domino' transplant preformed

Oct 03, 2006

U.S. transplant surgeons have performed a "domino" transplant procedure to save two patients suffering a life-threatening liver condition.

The surgeons at Children's Hospital of Pittsburgh and University of Pittsburgh Medical Center said it was only the nation's second domino transplant involving a patient with maple syrup urine disease.

Domino transplants are so named for the sequential nature of the procedure -- an organ from a deceased donor is transplanted into the first recipient. The first recipient's organ then is transplanted into a second recipient. Domino transplants are a rare, but effective, way of overcoming the shortage of organs available for transplant, physicians said.

The Pittsburgh surgeons transplanted a liver from an unidentified dead donor into Nickolai Rudd, an adult patient at Children's with MSUD, a rare and potentially life-threatening genetic disease. Rudd's liver was transplanted into James Paulshock, an adult suffering from liver failure caused by primary sclerosing cholangitis.

The MSUD that afflicted Rudd was not passed on to Paulshock through his donated liver, while Rudd's new liver metabolically cured his MSUD.

The transplants, performed May 30, were announced Monday and both patients' new livers are said to be functioning normally.

Copyright 2006 by United Press International

Explore further: Hartford consensus aims to improve survival after mass shootings

add to favorites email to friend print save as pdf

Related Stories

Biomaterial shows promise for Type 1 diabetes treatment

May 09, 2013

(Phys.org) —Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

Jun 18, 2013

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

Jun 18, 2013

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

User comments : 0

More news stories

LA to give every student an iPad; $30M order

Los Angeles' school system, the second largest in the United States, is ordering iPads for all its students, handing Apple a major success in its quest to make the tablet computer a replacement for textbooks.